 Inclusion Criteria:1. Patients are eligible if they have a histologically proven gastrointestinal cancer esophageal, gastroesophageal junction, gastric, small intestine, appendix, colon, rectum, anus, liver, gallbladder, bile ducts, pancreas, neuroendocrine, and GI stromal tumor. 